The Technical Analyst
Panacea Acquisition Corp. [PANA]
Exchange: NYSE Sector: Financial Services Industry: Shell Companies
Panacea Acquisition Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.10% $10.24
America/New_York / 18 apr 2023 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 241.10 mill |
| EPS: | 0.0600 |
| P/E: | 170.67 |
| Earnings Date: | Dec 30, 2022 |
| SharesOutstanding: | 23.55 mill |
| Avg Daily Volume: | 0.0695 mill |
| RATING 2023-04-26 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Buy |
| PE RATIO: COMPANY / SECTOR |
|---|
| 17.22x |
| Company: PE 170.67 | sector: PE 9.91 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 170.67 | industry: PE -11.98 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.21 - 10.27 ( +/- 0.26%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-04-28 | Ecor1 Panacea Holdings Ii, Llc | Sell | 545 000 | Class A ordinary shares |
| 2021-04-09 | Ecor1 Panacea Holdings Ii, Llc | Buy | 545 000 | Class A ordinary shares |
| 2020-04-06 | Ecor1 Panacea Holdings Ii, Llc | Buy | 0 | |
| 2021-04-06 | Platshon Scott | Buy | 0 | |
| 2021-04-06 | Perlen Scott | Buy | 0 |
| INSIDER POWER |
|---|
| -100.00 |
| Last 6 transactions |
| Buy: 935 000 | Sell: 4 063 750 |
Forecast:
01:40 - $10.27
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.24 (-0.10% ) |
| Volume | 0.114 mill |
| Avg. Vol. | 0.0695 mill |
| % of Avg. Vol | 164.52 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PANA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PANA
Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.
Latest Press Releases
2021-04-06 22:19:00 - Press Release
Panacea Acquisition Corp. Ii Announces Pricing Of $150,000,000 Initial Public Offering
San francisco, ca, april 06, 2021 (globe newswire) -- panacea acquisition corp. ii (the “company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 15,000,000 class a ordinary shares at a price of $10.00 per share. the company is sponsored by ecor1 panacea holdings ii, llc, an affiliate of ecor1 capital, llc. while the company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector that is domiciled in north america or europe.
2021-01-20 18:28:00 - Press Release
Panacea Announces Effectiveness Of Registration Statement For Proposed Business Combination With Nuvation Bio
San francisco--(business wire)--panacea acquisition corp., a delaware corporation (the “company”) (nyse: pana.u, pana, pana ws), announced today that its registration statement on form s-4 (file no. 333-250036) (as amended, the “registration statement”), relating to the previously announced business combination (the “business combination”) with nuvation bio inc. (“nuvation bio”), has been declared effective by the u.s. securities and exchange commission (“sec”) and that it has commenced mailing the definitive proxy statement/prospectus relating to the special meeting (the “special meeting”) of the company’s stockholders to be held on february 9, 2021 in connection with the business combination...
2020-08-20 16:50:00 - Press Release
Panacea Acquisition Corp. Announces The Separate Trading Of Its Shares Of Class A Common Stock And Redeemable Warrants Commencing August 21, 2020
New york--(business wire)--panacea acquisition corp. (nyse: pana.u) (the “company”) today announced that, commencing august 21, 2020, holders of the units sold in the company’s initial public offering of 14,375,000 units completed on july 6, 2020, may elect to separately trade the shares of class a common stock and redeemable warrants included in the units. those units not separated will continue to trade on the new york stock exchange (the “nyse”) under the symbol “pana.u,” and the shares of class a common stock and redeemable warrants that are separated will trade on the nyse under the symbols “pana” and “pana ws,” respectively. no fractional warrants will be issued upon separation of the units and only whole warrants will trade...
2020-06-30 18:17:00 - Press Release
Panacea Acquisition Corp. Announces Pricing Of $125,000,000 Initial Public Offering
New york--(business wire)--panacea acquisition corp. (the “company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. the company is sponsored by ecor1 panacea holdings, llc, an affiliate of ecor1 capital, llc. while the company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector. the units are expected to be listed on the new york stock exchange (the “nyse”) and trade under the ticker symbol “pana...
Latest News
2021-04-06 22:19:00 - GlobeNewsWire
Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering
SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 15,000,000 Class A ordinary shares at a price of $10.00 per share. The Company is sponsored by EcoR1 Panacea Holdings II, LLC, an affiliate of EcoR1 Capital, LLC. While the Company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector that is domiciled in North America or Europe.
2021-01-20 18:28:00 - Business Wire
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
SAN FRANCISCO--(BUSINESS WIRE)--Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333-250036) (as amended, the “Registration Statement”), relating to the previously announced business combination (the “Business Combination”) with Nuvation Bio Inc. (“Nuvation Bio”), has been declared effective by the U.S. Securities and Exchange Commission (“SEC”) and that it has commenced mailing